Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 25Neoplasms 12Giant Cell Tumor of Bone 10Prostatic Neoplasms 9Multiple Myeloma 9Neoplasm Metastasis 8Osteoporosis 4Fractures, Bone 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Kidney Neoplasms 3Carcinoma, Renal Cell 3Bone Neoplasms 3Bone Diseases, Metabolic 3Bone Diseases 3Spinal Cord Compression 2Smoldering Multiple Myeloma 2Parathyroid Neoplasms 2Melanoma 2Lymphoma 2Lung Neoplasms 2Giant Cell Tumors 2Bone Metastases 2Bone Cysts, Aneurysmal 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer Metastatic 1Paraproteinemias 1

Interventions

Denosumab 2X-Rays 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Cysts, Aneurysmal × Denosumab × Clear all
NCT03605199 2019-08-26

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

Leiden University Medical Center

Phase 2 Unknown
60 enrolled

Chondroblastoma, Granuloma, Giant Cell, Bone Cysts, Aneurysmal, Osteoblastoma

NCT03415477 2018-01-30

Deno-ABC

Peking University People's Hospital

Phase 1/2 Completed
6 enrolled

Fractures, Spontaneous, Neoplasms, Recurrence, Bone Cysts, Aneurysmal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡